|
RGP1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.5166982093624E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.15589784807935E-12 |
| Normal-vs-Stage2 |
2.08819999958365E-07 |
| Normal-vs-Stage3 |
9.74690000044021E-07 |
| Normal-vs-Stage4 |
4.47850001528138E-09 |
| Stage1-vs-Stage2 |
8.820200E-01 |
| Stage1-vs-Stage3 |
8.128800E-01 |
| Stage1-vs-Stage4 |
6.037900E-02 |
| Stage2-vs-Stage3 |
9.564000E-01 |
| Stage2-vs-Stage4 |
1.572170E-01 |
| Stage3-vs-Stage4 |
9.843900E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.68995936636429E-12 |
| Normal-vs-AfricanAmerican |
2.71810018936947E-10 |
| Normal-vs-Asian |
6.14930000253366E-08 |
| Caucasian-vs-AfricanAmerican |
8.833800E-01 |
| Caucasian-vs-Asian |
2.919500E-03 |
| AfricanAmerican-vs-Asian |
2.358400E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62925228863742E-12 |
| Normal-vs-Female |
1.35400000000896E-06 |
| Male-vs-Female |
9.279200E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.394400000021E-06 |
| Normal-vs-Extreme_Weight |
1.66444635851803E-12 |
| Normal-vs-Obese |
2.17289997106462E-09 |
| Normal-vs-Extreme_Obese |
5.23740000035744E-07 |
| Normal_Weight-vs-Extreme_Weight |
1.190970E-01 |
| Normal_Weight-vs-Obese |
9.506400E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.301400E-01 |
| Extreme_Weight-vs-Obese |
2.803800E-02 |
| Extreme_Weight-vs-Extreme_Obese |
7.770000E-01 |
| Obese-vs-Extreme_Obese |
3.929000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.7573000005443E-07 |
| Normal-vs-Age(41-60Yrs) |
1.60159996376308E-10 |
| Normal-vs-Age(61-80Yrs) |
5.99631455600047E-13 |
| Normal-vs-Age(81-100Yrs) |
2.79089999999371E-08 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.956400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.044400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.246600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.628200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.888800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.985400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.65334412827178E-12 |
| Normal-VS-Type2 PRCC |
4.91630003374155E-09 |
| Normal-VS-KIRP CIMP |
5.750200E-04 |
| Normal-VS-Unclassified PRCC |
5.63559999999796E-05 |
| Type1 PRCC-VS-Type2 PRCC |
6.458200E-02 |
| Type1 PRCC-VS-KIRP CIMP |
1.478030E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
9.899900E-03 |
| Type2 PRCC-VS-KIRP CIMP |
6.371000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
3.755600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
9.331400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.04121180963557E-14 |
| Normal-vs-N1 |
2.47840000000554E-06 |
| Normal-vs-N2 |
3.67110000000226E-05 |
| N0-vs-N1 |
2.948600E-01 |
| N0-vs-N2 |
5.738000E-01 |
| N1-vs-N2 |
4.063000E-01 |
|
|
